Latest news with #HCG
&w=3840&q=100)
Business Standard
24-05-2025
- Business
- Business Standard
HCG Q4 PAT drops 65% to ₹7.4 cr; acquires Orbitrap Astral from Thermo
Bengaluru-based HealthCare Global Enterprises (HCG) reported a 65 per cent decrease in consolidated profit after tax (PAT) to Rs 7.4 crore during the fourth quarter of the financial year ended March. HCG further announced the acquisition of the Orbitrap Astral Mass Spectrometer from Thermo Fisher Scientific. 'Looking ahead, we are making focused investments in next-generation capabilities, especially in early cancer detection and precision medicine. In line with our commitment to cutting-edge diagnostics and research, we are pleased to share that we are acquiring the Orbitrap Astral Mass Spectrometer from Thermo Fisher Scientific — one of the most advanced platforms globally for high-resolution mass spectrometry,' said BS Ajaikumar, executive chairman, HealthCare Global Enterprises. 'The acquisition will significantly enhance our molecular and proteomic profiling capabilities, enabling more precise disease characterisation and paving the way for next-generation biomarker discovery and targeted therapies,' said Ajaikumar. HCG reported operating income at Rs 585.1 crore in Q4FY25, up from Rs 494.6 crore in the same period last year. The company reported that revenues for HCG Onco Specialty Centres (excluding MGM) grew by a robust 16.7 per cent year-on-year in FY25. The quarter's earnings before interest, taxes, depreciation, and amortization (EBITDA) stood at Rs 107 crore, a growth of 14 per cent while maintaining a margin a margin of 18.3 per cent. For the company's established centers, EBITDA grew 15 per cent at Rs 115.4 crore, and emerging centers witnessed a Rs 7 crore increase from Rs 4.9 crore, year-on-year. 'Continuing our strategic focus on inorganic growth, we acquired MG Hospital in Vizag in FY25, further consolidating our presence and establishing HCG as the leading cancer care provider in that region. This acquisition marks our third in just 18 months, highlighting our consistent and focused approach to expansion,' said Raj Gore, CEO HealthCare Global Enterprises. HCG further emphasised its long-term commitment to building a robust academic and research foundation. Through fellowship programs and clinical research initiatives, the organisation aims to nurture the next generation of oncology leaders.
United News of India
24-05-2025
- Business
- United News of India
HCG posts Rs 5,851 million revenue in Q4 FY25
Bengaluru, May 24 (UNI) HealthCare Global Enterprises Ltd. (HCG), India's leading speciality healthcare provider focused on oncology and fertility, announced its unaudited financial results for the quarter and full year ended March 31, 2025. The company reported consolidated revenue of Rs 5,851 million for Q4 FY25, marking an 18% year-on-year growth from Rs 4,946 million in the corresponding quarter last year. For the full financial year 2025, HCG's revenue stood at Rs 22,228 million, reflecting a robust 16% growth over the previous year. EBITDA for Q4 FY25 was recorded at Rs 1,070 million, registering a 14% increase year-on-year, with margins at 18.3%. Profit After Tax (PAT) for the quarter was INR 74 million, down from Rs 213 million in Q4 FY24. Key operational highlights include a 3.5% rise in Average Revenue Per Operating Bed (ARPOB) to Rs 44,236, and an improvement in Average Occupancy Rate (AOR) to 67% from 63.2% in the previous year's quarter. The company also expanded its infrastructure by adding two Linear Accelerators (LINACs) at Vizag and Nagpur, and one PET CT facility in Africa. Dr BS Ajaikumar, Executive Chairman of HCG, said, "We have concluded another year of strong performance and meaningful progress. HCG continues to lead India's battle against cancer with a pan-India presence. We are investing in next-generation capabilities, including advanced molecular diagnostics and precision medicine. Our acquisition of the Orbitrap Astral Mass Spectrometer will significantly enhance our disease profiling and targeted therapy development." Raj Gore, CEO, added, "FY25 was a strong year operationally and financially. Excluding Milann centres, revenues grew by 17.4% to INR 21,651 million and Adjusted EBITDA increased 18.3% to Rs 3,913 million with margins of 18.1%. Our strategic acquisitions, including MG Hospital in Vizag, strengthen our regional presence and growth outlook. We remain confident about sustaining momentum into FY26.' HCG operates 22 comprehensive cancer centres across India and Africa and 7 fertility centres under the 'Milann' brand. UNI BDN RN
USA Today
22-05-2025
- Health
- USA Today
When should you take a pregnancy test? Here's what experts recommend.
When should you take a pregnancy test? Here's what experts recommend. Show Caption Hide Caption Preeclampsia: Symptoms, causes and treatments Preeclampsia is a high blood pressure condition that develops during pregnancy. Self Improved Taking a pregnancy test too early can produce a false negative result. And the prospect of a major life change like pregnancy is a time when you want to make sure you're getting the most accurate information. So how do you know when it's too early to take a pregnancy test, and at what point can you get accurate results? Dr. Karen Tang, author of "It's Not Hysteria: Everything You Need to Know About Your Reproductive Health (But Were Never Told)," explains what you need to know about the best times to take a pregnancy test – and signs to look out for that signify you could be pregnant in the first place. Noted: Can you actually get pregnant during your period? What an OB/GYN needs you to know. How early can you take a pregnancy test? The "most sensitive" drugstore tests can detect pregnancy as early as three or four weeks after your missing period date, Tang says. In those first few weeks, pregnancy hormones are on the rise every day. If you take a test early on that turns up negative but you still believe you may be pregnant, Johns Hopkins Medicine recommends testing again in a week. Getting a blood test done by a medical professional also may be helpful, as blood tests are able to detect pregnancy before urine tests and ultrasounds. "You should take a test as soon as you are worried you might be pregnant – but most over-the-counter tests may not turn positive until around the time that you'd be due for or missing your period," she adds. "Pregnancy hormone (HCG) is most concentrated in the first morning urine, so that may have the best chance of showing a positive, but obviously take the test whenever in the day you're able to." How does IVF work? Plus what the process is like and how much it costs. And FYI: Pregnancy is actually calculated from the first day of your last period, not the actual day of conception, Tang says.
Time of India
29-04-2025
- Health
- Time of India
Gas pipeline reaches city; Mihan, MIDC first to get connections
Nagpur: The much-awaited natural gas pipeline has finally reached the city, extending up to Nagpur Airport. In the coming years, the network is expected to expand across the city, making natural gas connections available to residents and providing them with 24x7 gas supply. Haryana City Gas (HCG), Nagpur, has been granted the license to supply natural gas in Nagpur district. HCG Nagpur's president (operations), Deepak Sawant, told TOI that the company received the licence from the Petroleum and Natural Gas Regulatory Board (PNGRB). "The natural gas will be supplied to HCG Nagpur by GAIL through the Mumbai-Nagpur-Jharsuguda pipeline. HCG will subsequently lay pipelines across the district to provide gas connections to households and industries. GAIL has extended the pipeline to Butibori, and from there, HCG is continuing the pipeline work," said Sawant, adding that GAIL will begin supplying gas to HCG from August. Sawant noted that HCG has already laid pipelines up to the airport, covering areas such as Mihan, Hingna MIDC, and Chinchbhavan. "We have started approaching large residential societies and industries in MIDC, Mihan, and near the cancer hospital. These societies will receive gas connections in the next few months. We are also conducting an awareness campaign to inform citizens about the pipeline. The regulatory body has given us eight years to complete the pipeline network across the district, with the timeline starting once gas supply begins," he said. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Simple Method Helps Burn Belly & Arm Fat (Watch) Health News Undo Initially, HCG will target areas on the city's outskirts, before expanding to regions such as Wardha Road, Narendra Nagar, Omkar Nagar, Manewada, Besa, Hingna, and Wadi. The pipeline will first be laid in outer areas before reaching the city center. "Areas like Narendra Nagar and Wadi are expected to receive gas connections within one to two years," Sawant added. The entire project is valued at Rs1,000 crore, with HCG having invested approximately Rs200 crore so far in pipeline laying and establishing CNG pumps. "We are currently transporting liquid gas from Gujarat to supply at our 25 CNG pumps. This liquid gas is costlier due to tanker transportation. Once the pipeline is operational, it will be more cost-effective and convenient," Sawant explained. As the gas pipeline is a utility project, several city roads are likely to be dug in the coming years to facilitate the pipeline installation.
Time of India
25-04-2025
- Health
- Time of India
Chief Minister Bhupendra Patel inaugurates Gujarat's largest private cancer centre at HCG Aastha Cancer Centre, Ahmedabad
The new facility combines advanced technology, enhanced capacity, and holistic care, reaffirming HCG's commitment to accessible, world-class oncology in Gujarat In a noteworthy development for cancer care in Gujarat, Bhupendra Patel , the Chief Minister of Gujarat, inaugurated the expanded HCG Aastha Cancer Centre in its new premises opposite Bhagwat Vidyapith, Sola. Now the largest private comprehensive cancer care centre in the state, the inauguration was attended by HCG's senior leadership, Dr BS Ajaikumar, Raj Gore, Dr Bharat Gadhavi, and Sudharshan Bhamare, marking a significant leap forward in delivering accessible, world-class oncology care to the region. With increased capacity, next-generation technology, and a holistic care model, the upgraded facility reinforces HCG Aastha Cancer Centre Ahmedabad's commitment to delivering integrated, high-impact cancer treatment to patients across Gujarat and beyond. With a 217-bed capacity, a 140 per cent increase from its previous strength, the hospital is now equipped to handle significantly higher patient volumes with enhanced efficiency and personalised care. This includes 23 surgical ICU beds, 10 medical ICU beds, 23 daycare beds, 16 pre- and post-operative beds, and 6 Bone Marrow Transplant (BMT) units. This capacity boost will enable the hospital to manage a projected 30-40 per cent increase in patient footfall, translating to over 55,000 outpatient visits and 9,000 inpatient admissions annually. Backed by a multidisciplinary team of over 100 in-house doctors, the centre offers seamless, end-to-end care across surgical, medical, and radiation oncology, nuclear medicine, paediatric haemato-oncology, and advanced diagnostics. Speaking on the occasion, Bhupendra Patel, the Chief Minister of Gujarat, said, 'The launch of the HCG Aastha Cancer Centre in Ahmedabad is a significant step forward in making advanced cancer care more accessible. With its cutting-edge technology, the hospital provides excellent cancer treatment. The expertise of the hospital's highly experienced and dedicated team will significantly benefit the patients. I also applaud HCG for setting up a trust to support needy patients.' The Chief Minister highlighted the importance of healthy living, saying, 'Prime Minister Shri Narendra Modi has ensured the availability of comprehensive health initiatives—from yoga to Ayushman Bharat. Everyone should pay attention to their lifestyle to maintain good health.' Dr BS Ajaikumar, Executive Chairman, Healthcare Global Enterprises Limited, said, 'At HCG, our core philosophy has always been to deliver the right treatment the first time. We believe that quality cancer care should never be limited by geography. The expansion of HCG Aastha Cancer Centre in Ahmedabad is not merely an infrastructure milestone — it is a reaffirmation of our commitment to making advanced, evidence-based oncology accessible to every patient, no matter where they live. This centre brings together cutting-edge technology, organ-specific expertise, and a deeply compassionate care model, setting the benchmark for the future of cancer treatment. In this era of precision medicine, we are increasingly focused on leveraging genomics and proteomics to better understand tumour biology and guide personalised therapies. This approach enables us to improve outcomes, even in advanced and recurrent cases. With this facility, we strengthen our resolve to make high-quality cancer care more accessible, affordable, and outcome-driven — not just for Gujarat, but for all of India.' Raj Gore, CEO, Healthcare Global Enterprises Limited, added, 'The launch of the new premise with the upgraded facility at HCG Aastha Cancer Centre marks a strategic milestone in our ongoing mission to redefine cancer care in India. This facility not only reinforces our leadership in oncology but also aligns with our long-term vision to make world-class, technology and quality-driven cancer treatment more accessible. By integrating advanced modalities such as robotic-assisted surgeries with the expertise of our multidisciplinary teams, we aim to set new benchmarks in precision oncology and improve patient outcomes across the region.' Dr Bharat Gadhavi, Regional Director, HCG Group of Hospitals, Gujarat and Rajasthan , added, 'This state-of-the-art centre integrates cutting-edge clinical infrastructure, efficient processes, and a dedicated team to deliver more effective and personalised treatment. With this expansion, we are better equipped to offer patients the specialised care they need for improved outcomes. Since beginning its journey in Gujarat in 2007, HCG has established comprehensive cancer care facilities in Rajkot, Bhavnagar, and Vadodara. This new facility further strengthens our commitment to providing holistic cancer care under one roof, becoming a hub for managing complex and recurrent cases.' Sudharshan Bhamare, COO, HCG Astha Cancer Centre , Ahmedabad, added, 'This centre has been a conscious investment to meet the growing cancer care needs of Gujarat. From increasing bed strength to introducing specialised ICUs and surgical units, every aspect has been designed to handle more complex cases efficiently. This enhanced centre also enables us to reduce wait times, enhance patient comfort, and offer advanced treatments under one roof.' The centre continues to elevate its precision-led treatment approach through the integration of advanced technologies — including robotic surgery for GI, urological, and gynaecological cancers, Gujarat's first Tomo Therapy unit, and scalp cooling technology to help reduce chemotherapy-induced hair loss — a regional first. In addition to clinical upgrades, the expanded facility enhances its patient support ecosystem with services such as genetic counselling, multilingual international patient assistance, home and palliative care, and peer-led survivor support groups facilitated by the HCG Foundation and Ahmedabad Cancer Foundation. With this landmark expansion, HCG Aastha Cancer Centre, Ahmedabad, not only strengthens its leadership in oncology but also sets a new benchmark for patient-centric, compassionate innovation in cancer care for Gujarat and beyond. Disclaimer - The above content is non-editorial, and TIL hereby disclaims any and all warranties, expressed or implied, relating to it, and does not guarantee, vouch for or necessarily endorse any of the content. Stay informed with the latest business news, updates on bank holidays and public holidays . Master Value & Valuation with ET! Learn to invest smartly & decode financials. Limited seats at 33% off – Enroll now!
